Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Enzychem Lifesciences announces filing of US provisional patent for EC-18 to treat COVID-19

pharmaceutical-business-reviewApril 15, 2020

Tag: COVID-19 , Enzychem Lifesciences , EC-18

PharmaSources Customer Service